98%
921
2 minutes
20
Poly- and perfluoroalkyl substances (PFAS) have been investigated in a number of cohort studies due to concern over their adverse health effects. The aim of this study was to develop a reliable, high throughput and cost-effective analytical method for a broad range of PFAS in human serum. Protein precipitation, automatic solid phase extraction (SPE) pre-treatment and column-switching LC-MS/MS were employed. The optimised and validated method was then used to analyse the levels of 28 PFAS in 339 maternal serum samples from Pilot Study of the Japan Environment and Children's Study. Perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluoroundecanoic acid (PFUnA) and perfluorooctane sulphonic acid (PFOS) were detected in all 339 samples at median (range) concentrations of 1.9 (0.46-15), 1.5 (0.32-10), 1.3 (0.25-4.5) and 3.7 (0.43-15) ng/ml, respectively. These levels are comparable to those reported in previous studies using samples collected from various parts of the world. With a few exceptions, the remainder of the PFAS examined had lower detection rates but were found at concentrations similar to those reported in previous studies. The sensitivity and throughput ability of the method developed here are sufficient for its application in a large-scale biomonitoring study.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chroma.2020.460933 | DOI Listing |
Small
August 2025
Department of Chemistry and Biochemistry, Florida International University, Miami, Florida, 33199, USA.
Poly/perfluoroalkyl substances (PFAS) have emerged as contaminants of global concern due to their extreme persistence, bioaccumulation, and toxicity. Conventional wastewater treatment technologies are ineffective for PFAS removal, prompting increasing interest in photochemical degradation as a promising alternative. Among these, homogeneous ultraviolet (UV) based systems and heterogeneous photocatalysis have attracted significant attention, while a comprehensive mechanistic discussion and comparison of these approaches remains fragmented.
View Article and Find Full Text PDFEcotoxicol Environ Saf
August 2025
School of Public Health, Guangdong Medical University, Dongguan 523808, PR China. Electronic address:
Increasing evidence indicates that traditional poly- and perfluoroalkyl substances (PFAS) may affect platelet function. However, the impact of mixed PFAS exposure on platelets and the specific contributions of each chemical remain unclear. Furthermore, the potential mechanisms involved are largely unknown.
View Article and Find Full Text PDFJ Immigr Minor Health
August 2025
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Canada.
Immigrants in the United States may experience varying levels of exposure to perfluoroalkyl substances (PFAS) depending on their duration of residency and their region of origin. PFAS are persistent environmental pollutants linked to adverse health outcomes, yet little is known about exposure levels among immigrant populations. This cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES) 2003-2018 to assess serum PFAS concentrations among adults by length of U.
View Article and Find Full Text PDFEnviron Sci Process Impacts
August 2025
Department of Chemistry, York University, Toronto, M3J 1P3, Canada.
Acidic pollutants have long been known to have detrimental impacts on remote ecosystems. They have been subject to assessment through long-term monitoring with low cost methodologies, such as passive sampling. Atmospheric oxidation is becoming recognized as a source of persistent perfluorinated carboxylic acids (PFCAs) derived from volatile poly- and perfluorinated alkyl substance (PFAS) precursors.
View Article and Find Full Text PDFEnviron Res
August 2025
School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Box 453, Gothenburg, 405 30, Sweden.
Background: Many poly- and perfluoroalkyl substances (PFAS) are persistent and have long half-lives in the human body. However, there are limited data on the different routes of elimination. Most pharmacokinetic models assume that the urinary route dominates.
View Article and Find Full Text PDF